Glucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats

BACKGROUND: Glucagon-like peptide-1 (GLP-1) has been reported to exert some beneficial effects on the central nervous system (CNS). However, the effect of GLP-1 on cognitive impairment associated with type 2 diabetes is not well known. This study investigated the effect of GLP-1 on ameliorating memo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xiang-Sheng, Tan, Zhao-Guang, Li, Jing-Jing, Gao, Wei-Hong, Li, Shu-Ji, Li, Jin-Long, Tang, Yong-Ming, Li, Hong-Wei, Hui, Hong-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601394/
https://www.ncbi.nlm.nih.gov/pubmed/28885995
http://dx.doi.org/10.12659/MSM.903252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601394/
https://www.ncbi.nlm.nih.gov/pubmed/28885995
http://dx.doi.org/10.12659/MSM.903252

Ejemplares similares